Template:Intraocular lymphoma: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''T...") |
No edit summary |
||
Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
''' | '''Intraocular lymphoma Microchapters | ||
''' | ''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
Line 10: | Line 10: | ||
|- bgcolor="LightCoral" | |- bgcolor="LightCoral" | ||
! | ! | ||
[[ | [[Intraocular lymphoma|Home]] | ||
|- | |- | ||
! | ! | ||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 22: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma overview|Overview]] | ||
|- | |- | ||
! | ! | ||
Line 28: | Line 28: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 34: | Line 34: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma differential diagnosis|Differentiating Intraocular lymphoma from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Intraocular lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 88: | Line 82: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Intraocular lymphoma history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 112: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Intraocular lymphoma physical examination|Physical Examination]] | ||
|- | |- | ||
! | ! | ||
Line 118: | Line 94: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Intraocular lymphoma laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 124: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Intraocular lymphoma CT|CT]] | ||
|- | |- | ||
! | ! | ||
Line 130: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Intraocular lymphoma MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
Line 136: | Line 112: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Intraocular lymphoma other imaging findings|Other Imaging Findings]] | ||
|- | |- | ||
! | ! | ||
Line 142: | Line 118: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Intraocular lymphoma other diagnostic studies|Other Diagnostic Studies]] | ||
|- | |- | ||
! | ! | ||
Line 154: | Line 130: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Intraocular lymphoma medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 160: | Line 136: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Intraocular lymphoma surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Line 166: | Line 142: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Intraocular lymphoma primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 172: | Line 148: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Intraocular lymphoma secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 178: | Line 154: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Intraocular lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 184: | Line 160: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Intraocular lymphoma future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
Line 196: | Line 172: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Intraocular lymphoma case study one|Case #1]] | ||
|- | |- | ||
! | ! | ||
Line 297: | Line 273: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+ | [http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Intraocular lymphoma}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Intraocular lymphoma] | ||
|- | |- | ||
! | ! |
Latest revision as of 15:15, 12 September 2012
Intraocular lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Intraocular lymphoma On the Web |
American Roentgen Ray Society Images of Intraocular lymphoma |